Answers are grounded in this paper and cite their sources.
Observational study analyzes cardiovascular risk ties to lipid markers in type 1 diabetes patients, suggesting early detection strategies.
Background/Introduction Diabetic ketoacidosis (DKA) is a state of absolute insulin deficiency potentiated by acute lipotoxicity. Acute hyperglycemia increases cardiovascular (CV) risk, while CV disease remains the leading cause of mortality in people with type 1 diabetes (T1D). However, the mechanisms through which CV risk is mediated in T1D remain insufficiently explored. Purpose Study aim was to analyze the relationship between lipid markers and CV risk in patients with T1D and DKA. Methods A retrospective observational study, including 65 T1D patients with DKA, and no prior CV event, was conducted. CV risk was assessed using the Steno type 1 risk engine (ST1RE) score, dividing patients into three groups, group A (low risk, n = 32), B (moderate risk, n = 23) and C (high risk, n = 10). Anthropometric and biochemical parameters were evaluated, including lipid indices: triglyceride glucose index (TyGI), visceral adiposity index (VAI), Castelli risk index I and II (CRI-I and CRI-II), atherogenic index of plasma (AIP) and atherogenic coefficient (AC). Results Significant difference was observed between the groups regarding diabetes duration (4.6±1.1y vs. 7.8±2.8y vs. 10.1±3.7y, p=0.04), time to DKA resolution (12.5±3.1h vs. 13.3±4.2h vs. 15.7±2.1h, p=0.048), waist circumference (81.2±4.3cm vs. 84.1±5.2cm vs. 87.1±4.4cm, p<0.05), waist/height ratio (0.47±0.07 vs. 0.49±0.05 vs. 0.50±0.1, p=0.045), total cholesterol (6.2±2.1mmol/l vs. 6.5±1.2mmol/l vs. 6.8±2.1, p<0.05), triglycerides (7.2±2.2mmol/l vs. 7.5±1.6mmol/l vs. 7.6±1.1, p<0.05), TygI (5.4±1.2 vs. 5.6±1.1 vs. 5.7±0.8, p<0.05), VAI (15.1±4.3 vs. 16.2±3.8 vs. 16.8±3.1, p<0.05) and CRI-I (8.6±1.3 vs. 10.7±2.2 vs. 11.7±1.9, p<0.05). Multivariable regression analysis showed that TygI, VAI and CRI-I were independently associated with high CV risk. Conclusion(s) Our results indicate that lipid indices, as surrogate markers of atherosclerosis and visceral adiposity, may be useful for early detection of elevated CV risk in patients with T1D and DKA.
No takes yet. Share an insight, caveat, or question.
Božović et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: